Highlights Elutia Inc.

Equities

ELUT

US05479K1060

Market Closed - Nasdaq Other stock markets 04:30:00 2024-06-12 pm EDT			5-day change	1st Jan Change
3.8 ^USD	-4.16%		+13.67%	+75.93%

May. 09	Elutia Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
May. 09	Earnings Flash (ELUT) ELUTIA Posts Q1 Revenue $6.7M, vs. Street Est of $6.1M	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Elutia Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 09	CI
Earnings Flash (ELUT) ELUTIA Posts Q1 Revenue $6.7M, vs. Street Est of $6.1M	May. 09	MT
Elutia Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 07	CI
Elutia Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 07	CI
Earnings Flash (ELUT) ELUTIA Posts Q4 Revenue $5.9M, vs. Street Est of $6.6M	Mar. 07	MT
Elutia Submits CanGaroo Antibiotic-Eluting Biomatrix for FDA Clearance	Dec. 18	CI
Elutia Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Earnings Flash (ELUT) ELUTIA Reports Q3 Revenue $6.1M, vs. Street Est of $7.3M	Nov. 13	MT
Berkeley Biologics, LLC completed the acquisition of Orthobiologics business unit of Elutia Inc. for $34.6 million.	Nov. 07	CI
GNI Group Plans to Buy Portion of Elutia's Orthobiologics Business	23-09-20	MT
North American Morning Briefing : Stock Futures Lack Momentum as Fed Decision Looms	23-09-19	DJ
Elutia Sells Orthobiologics Business Unit For Up to $35 Million	23-09-18	MT
Berkeley Biologics, LLC entered into an Asset Purchase Agreement Orthobiologics business unit of Elutia Inc. for $35 million.	23-09-17	CI
Aziyo Biologics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Earnings Flash (AZYO) AZIYO BIOLOGICS Posts Q2 Revenue $10.3M, vs. Street Est of $12.5M	23-08-14	MT
Aziyo Biologics Voluntarily Recalls Bone-Repair Products	23-07-13	MT
Aziyo Biologics, Inc. Announces the Voluntary Recall of Its Viable Bone Matrix Products	23-07-13	CI
Aziyo Biologics, Inc. Presents Positive Clinical Data on Cangaroo® Biologic Envelope	23-05-19	CI
Aziyo Biologics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10	CI
Aziyo Biologics and LeMaitre Vascular Partner for the Distribution of Aziyo's Cardiovascular Portfolio	23-04-21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Elutia Inc.

Equities

ELUT

US05479K1060

Highlights

Filters